Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William P Harris

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2021
Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III TrialMary F Mulcahy, Armeen Mahvash, Marc Pracht, et al.
Cancers|June 13, 2025
Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary CancersGentry G King, Kelsey K Baker, Andrew L Coveler, et al.
The Lancet. Oncology|May 17, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2020
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO GuidelineJohn D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, et al.
JAMA Oncology|September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy TrialAndrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2021
Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III TrialMary F Mulcahy, Armeen Mahvash, Marc Pracht, et al.
Cancers|June 13, 2025
Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary CancersGentry G King, Kelsey K Baker, Andrew L Coveler, et al.
The Lancet. Oncology|May 17, 2020
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 studyGhassan K Abou-Alfa, Teresa Macarulla, Milind M Javle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2020
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO GuidelineJohn D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, et al.
JAMA Oncology|September 23, 2021
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation: The Phase 3 Randomized Clinical ClarIDHy TrialAndrew X Zhu, Teresa Macarulla, Milind M Javle, et al.
Pageof 4